EverGlade Consulting Helps GeoVax Secure up to $45 Million in BARDA Funding
EverGlade Consulting Helps GeoVax Secure up to $45 Million in BARDA Funding
"At EverGlade we pride ourselves on empowering our clients through strategic guidance and robust support. The recent BARDA award to GeoVax is not just a win for our client, but a promising advancement for global health. We are honored to contribute to the development of innovative vaccine technologies that aim to protect communities and save lives," stated EverGlade Consulting Founder, By Stephen Richardson, Managing Consultant and Eric Jia-Sobota, Founder
由Managing Consultant Stephen Richardson和Founder Eric Jia-Sobota撰寫
HOUSTON, Aug. 28, 2024 /PRNewswire/ -- EverGlade Consulting, a national consulting firm, has helped GeoVax Labs, Inc successfully secure up to $45 million in funding to advance the development of GEO-CM04S1, GeoVax's dual-antigen next-generation COVID-19 vaccine through the Rapid Response Portfolio Vehicle (RRPV) consortium funded by the Biomedical Advanced Research and Development Authority ("BARDA").
休斯頓，2024年8月28日 / PRNewswire / - 全國諮詢公司EverGlade Consulting已幫助geovax labs成功獲得4500萬美元的資金，以推進GEO-CM04S1的研發，這是GeoVax的雙抗原下一代COVID-19疫苗，通過生物醫藥先進研究和發展局（"BARDA"）資助的快速響應組合車（RRPV）財團。
The $45 million in BARDA funding will fund the manufacturing of clinical materials and support for the Phase 2b clinical trial. Under the agreement, GeoVax will sponsor a 10,000-participant, randomized, Phase 2b double-blinded study to compare the efficacy, safety, and immunogenicity of GEO-CM04S1 with a FDA-approved mRNA COVID-19 vaccine. Preparations for the study are underway, and execution of the study will be fully funded by BARDA under its Clinical Studies Network.
4500萬美元的BARDA資金將用於資助臨床材料的生產和支持第20億臨床試驗。根據協議，geovax labs將資助一項由1萬名參與者組成的、隨機分組的、第20億期雙盲研究，以比較GEO-CM04S1的療效、安全性和免疫原性與一種獲得FDA批准的mRNA COVID-19疫苗。該研究的準備工作正在進行中，並且該研究的執行將完全由BARDA在其臨床研究網絡下資助。
"At EverGlade we pride ourselves on empowering our clients through strategic guidance and robust support. The recent BARDA award to GeoVax is not just a win for our client, but a promising advancement for global health. We are honored to contribute to the development of innovative vaccine technologies that aim to protect communities and save lives," stated EverGlade Consulting Founder, Eric Jia-Sobota
"在EverGlade，我們以戰略指導和強有力的支持賦予客戶力量爲傲。最近BARDA授予geovax labs的獎項不僅是我們客戶的勝利，也是全球衛生的一個有希望的進步。我們很榮幸能夠爲旨在保護社區和拯救生命的創新疫苗技術的發展做出貢獻。" EverGlade Consulting創始人Eric Jia-Sobota表示。
Funding for this award is provided under Project NextGen, a $5 billion initiative by HHS to advance a pipeline of new, innovative vaccines and therapeutics providing broader and more durable protection for COVID-19 than the first generation COVID vaccines and medicines. BARDA is supporting the development of new vaccines and therapeutics to better address the waning immunity and resistance to current and future SARS-CoV2 viral strains. GeoVax's vaccine candidate provides many of the features identified by BARDA including broader protection among variants of concern (VOC) and a longer duration of protection.
該獎項的資金來自HHS下一代項目，該項目是一個50億美元的倡議，旨在推進一系列新的創新疫苗和治療手段，提供比第一代COVID疫苗和藥物更廣泛和更持久的保護。BARDA支持開發新的疫苗和治療手段，以更好地應對當前和未來SARS-CoV2病毒株的減退免疫和對抗力。geovax labs的疫苗候選者提供了BARDA識別的許多特徵，包括對關注的變種（VOC）更廣泛的保護和更長時間的保護。
"Geovax is a proud and highly satisfied client of EverGlade. We recommend this team to those in pursuit of and as a recipient of a BARDA award," stated GeoVax Labs Chairman & CEO, David Dodd.
"geovax labs是EverGlade引以爲豪和高度滿意的客戶。我們向那些正在追求並獲得BARDA獎項的人推薦這個團隊。" geovax labs主席兼首席執行官David Dodd表示。
If your company has considered applying for BARDA funding, your federal funding journey starts here. EverGlade Consulting is a national consulting firm that helps organizations win and manage federal awards. We offer services ranging from Pursuit, Proposal and Post-Award support to comply with federal regulations at agencies including BARDA, ASPR, NIH, DTRA, JPEO, DOD, DIU, DOE, and DARPA.
如果貴公司考慮申請BARDA基金，您的聯邦資金之旅從這裏開始。EverGlade Consulting是一家全國性諮詢公司，幫助組織贏得和管理聯邦獎勵。我們提供的服務包括追求、提案和後獎勵支持，以便在包括BARDA、ASPR、NIH、DTRA、JPEO、DOD、DIU、DOE和DARPA在內的機構遵守聯邦規章。
For additional information about EverGlade Consulting, reach out to:
如需了解更多關於EverGlade Consulting的信息，請聯繫：
[email protected]
[email protected]
SOURCE EverGlade Consulting
來源：EverGlade Consulting
譯文內容由第三人軟體翻譯。